Open Access

LINC00565 promotes the progression of colorectal cancer by upregulating EZH2

  • Authors:
    • Xiaxia Shao
    • Tao Zhao
    • Lei Xi
    • Yuhong Zhang
    • Jia He
    • Jie Zeng
    • Lichun Deng
  • View Affiliations

  • Published online on: November 18, 2020     https://doi.org/10.3892/ol.2020.12314
  • Article Number: 53
  • Copyright: © Shao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to illustrate the role of LINC00565 in aggravating colorectal cancer (CRC) by targeting enhancer of zeste homolog 2 (EZH2). The relative levels of LINC00565 and EZH2 in CRC tissues, based on their Tumor‑Node‑Metastasis stage and tumor size, were detected by reverse transcription‑quantitative polymerase chain reaction. The diagnostic value of LINC00565 in CRC was assessed by depicting receiver operating characteristic curves. Pearson's correlation test was applied to analyze the expression correlation between LINC00565 and EZH2 in CRC tissues. The transfection efficacy of three LINC00565 small interfering RNAs was examined in CRC HCT116 and SW480 cell lines. After knockdown of LINC00565, the proliferative and migratory abilities of CRC cells were detected by Cell Counting Kit‑8 and Transwell assays, respectively. The subcellular distribution of LINC00565 was analyzed, and the interaction between LINC00565 and EZH2 was determined by RNA immunoprecipitation. Finally, co‑regulation of LINC00565 and EZH2 on CRC cell functions was explored by performing rescue experiments. Results showed that LINC00565 was upregulated in CRC tissues, especially in patients with stage III+IV and in those with large tumor sizes, suggesting its diagnostic value in CRC. EZH2 was also upregulated in CRC tissues, showing a positive correlation with LINC00565. LINC00565 was mainly expressed in the cytoplasm and was found to bind with EZH2. Validation was performed by overexpressing EZH2, which abolished the role of silenced LINC00565 in regulating proliferative and migratory abilities in CRC. Therefore, the upregulation of LINC00565 in CRC tissues was found to stimulate the aggravation of CRC by upregulating EZH2.
View Figures
View References

Related Articles

Journal Cover

January-2021
Volume 21 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shao X, Zhao T, Xi L, Zhang Y, He J, Zeng J and Deng L: LINC00565 promotes the progression of colorectal cancer by upregulating EZH2. Oncol Lett 21: 53, 2021
APA
Shao, X., Zhao, T., Xi, L., Zhang, Y., He, J., Zeng, J., & Deng, L. (2021). LINC00565 promotes the progression of colorectal cancer by upregulating EZH2. Oncology Letters, 21, 53. https://doi.org/10.3892/ol.2020.12314
MLA
Shao, X., Zhao, T., Xi, L., Zhang, Y., He, J., Zeng, J., Deng, L."LINC00565 promotes the progression of colorectal cancer by upregulating EZH2". Oncology Letters 21.1 (2021): 53.
Chicago
Shao, X., Zhao, T., Xi, L., Zhang, Y., He, J., Zeng, J., Deng, L."LINC00565 promotes the progression of colorectal cancer by upregulating EZH2". Oncology Letters 21, no. 1 (2021): 53. https://doi.org/10.3892/ol.2020.12314